Selecting Optimal Upfront Therapy for Ovarian Cancer

Selecting Optimal Upfront Therapy for Ovarian Cancer

How to determine best first line treatment for ovarian cancer?Подробнее

How to determine best first line treatment for ovarian cancer?

Is It Time to Change Upfront Chemotherapy for Ovarian Cancer?Подробнее

Is It Time to Change Upfront Chemotherapy for Ovarian Cancer?

Updates on criteria for patient selection and surgical management in advanced ovarian cancerПодробнее

Updates on criteria for patient selection and surgical management in advanced ovarian cancer

Dr. Crafton on Optimizing Treatment Selection in Recurrent Ovarian CancerПодробнее

Dr. Crafton on Optimizing Treatment Selection in Recurrent Ovarian Cancer

Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trialПодробнее

Selecting patients to be treated with maintenance olaparib in the PAOLA-1 trial

Treatment Options in Stage IIIc Ovarian CancerПодробнее

Treatment Options in Stage IIIc Ovarian Cancer

Gynecologic Oncology at ASCO 2021: Upfront Therapy in Ovarian CancerПодробнее

Gynecologic Oncology at ASCO 2021: Upfront Therapy in Ovarian Cancer

Dr. Salani on the Progression of Upfront Ovarian Cancer TreatmentПодробнее

Dr. Salani on the Progression of Upfront Ovarian Cancer Treatment

ovarian cancer 2021: Recent advance in treatmentПодробнее

ovarian cancer 2021: Recent advance in treatment

Frontline Bevacizumab Strategies in Ovarian CancerПодробнее

Frontline Bevacizumab Strategies in Ovarian Cancer

New Developments in Ovarian Cancer SurgeryПодробнее

New Developments in Ovarian Cancer Surgery

Ovarian Cancer: Selecting Between Available PARPsПодробнее

Ovarian Cancer: Selecting Between Available PARPs

TRUST: optimal timing of surgical therapy in advanced ovarian cancerПодробнее

TRUST: optimal timing of surgical therapy in advanced ovarian cancer

Dr. Boisen on Neoadjuvant Chemotherapy Versus Upfront Surgery in Ovarian CancerПодробнее

Dr. Boisen on Neoadjuvant Chemotherapy Versus Upfront Surgery in Ovarian Cancer

Ovarian Cancer Patient has Extraordinary Response to Clinical Trial TreatmentПодробнее

Ovarian Cancer Patient has Extraordinary Response to Clinical Trial Treatment

Ovarian Cancer: Standards of Care and New Opportunities - Dr. Robert ColemanПодробнее

Ovarian Cancer: Standards of Care and New Opportunities - Dr. Robert Coleman

What’s the Latest in Clear Cell Ovarian Cancer?Подробнее

What’s the Latest in Clear Cell Ovarian Cancer?

Patient Selection for Bevacizumab in Ovarian CancerПодробнее

Patient Selection for Bevacizumab in Ovarian Cancer

События